Demo Sign up Log In

Cartesian Therapeutics Inc (RNAC)

Debt to Equity

-0.51×

Quarterly · Period ending: Jun 30, 2026

RNAC Debt to Equity

Latest reported-0.51×period endingJun 30, 2026

Latest reported-0.51×period endingJun 30, 2026

RNAC Quarterly Debt/Equity (0.00× → -0.51×)

Latest values, visible window

High-resolution chart · PNG

RNAC debt to equity history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cartesian Therapeutics Inc Debt to Equity — Quarterly
Period ending	Debt to Equity
Jun 30, 2026	-0.5099×
Mar 31, 2026	-0.08×
Dec 31, 2025	-0.1004×
Sep 30, 2025	-0.3516×
Jun 30, 2025	-5.2825×
Mar 31, 2025	-0.6456×
Dec 31, 2024	-2.0559×
Sep 30, 2024	19.4827×
Jun 30, 2024	-0.1465×
Mar 31, 2024	-0.0895×
Dec 31, 2023	-0.0249×
Sep 30, 2023	0.1737×
Jun 30, 2023	0.5335×
Mar 31, 2023	0.506×
Dec 31, 2022	0.4042×
Sep 30, 2022	0.4493×
Jun 30, 2022	0.3913×
Mar 31, 2022	0.6302×
Dec 31, 2021	1.5666×
Sep 30, 2021	-1.8854×
Jun 30, 2021	-8.3709×
Mar 31, 2021	-1.8066×
Dec 31, 2020	-1.9631×
Sep 30, 2020	-4.7887×
Jun 30, 2020	-2.0381×
Mar 31, 2020	-3.2789×
Dec 31, 2019	2.2957×
Sep 30, 2019	-4.4071×
Jun 30, 2019	404.1607×
Mar 31, 2019	1.5449×
Dec 31, 2018	-3.947×
Sep 30, 2018	2.1299×
Jun 30, 2018	0.8743×
Mar 31, 2018	0.5081×
Dec 31, 2017	0.4061×
Sep 30, 2017	0.322×
Jun 30, 2017	0.1323×
Mar 31, 2017	0.2771×
Dec 31, 2016	0.2192×
Sep 30, 2016	0.183×
Jun 30, 2016	0.1732×
Mar 31, 2016	0.8257×
Dec 31, 2015	-0.1018×
Sep 30, 2015	0×
Jun 30, 2015	0×
Mar 31, 2015	0×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.